Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine E Mona

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
PET Clinics|March 29, 2023
Fibroblast Activation Protein Inhibitor Theranostics: Preclinical Combination TreatmentKatharina Lückerath, Marija Trajkovic-Arsic, Christine E Mona
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 11, 2020
Immune-Checkpoint Blockade Enhances <sup>225</sup>Ac-PSMA617 Efficacy in a Mouse Model of Prostate CancerJohannes Czernin, Kyle Current, Christine E Mona, et al.
EJNMMI Radiopharmacy and Chemistry|March 24, 2025
Hematological toxicity of [<sup>225</sup>Ac]Ac-PSMA-617 and [<sup>177</sup>Lu]Lu-PSMA-617 in RM1-PGLS syngeneic mouse modelMeryl Maria Vilangattil, Abir Swaidan, Jonathan Godinez, et al.
Organic & Biomolecular Chemistry|November 3, 2016
Design, synthesis, and biological evaluation of CXCR4 ligandsChristine E Mona, Élie Besserer-Offroy, Jérôme Cabana, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 16, 2025
FAP Expression in Renal Tumors Assessed by [<sup>68</sup>Ga]Ga-FAPI-46 PET Imaging and FAP Immunohistochemistry: A Case Series of Six Patients from the Prospective Exploratory Trial NCT04147494Adrien Holzgreve, Lena M Unterrainer, Kimberly Flores, et al.
Pharmacological Research|March 11, 2020
Cell-penetrating pepducins targeting the neurotensin receptor type 1 relieve painRebecca L Brouillette, Élie Besserer-Offroy, Christine E Mona, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 11, 2024
Preclinical evaluation of <sup>225</sup>Ac-labeled minigastrin analog DOTA-CCK-66 for Targeted Alpha TherapyNadine Holzleitner, Meryl Vilangattil, Abir Swaidan, et al.
Journal of Medicinal Chemistry|July 20, 2016
Structure-Activity Relationship and Signaling of New Chimeric CXCR4 AgonistsChristine E Mona, Élie Besserer-Offroy, Jérôme Cabana, et al.
ACS Pharmacology & Translational Science|July 15, 2026
Development of Radioligand Therapy-Responsive Syngeneic Prostate Models through Murine Prostate-Specific Membrane Antigen Point MutationMathis Richard, Beatrice Louis, Marco F Taddio, et al.
Clinical Nuclear Medicine|May 5, 2023
FAPI PET Signal in Hibernoma Reflects FAP Expression in Tumor Vasculature CellsMasatoshi Hotta, Christine E Mona, Joseph G Crompton, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
PET Clinics|March 29, 2023
Fibroblast Activation Protein Inhibitor Theranostics: Preclinical Combination TreatmentKatharina Lückerath, Marija Trajkovic-Arsic, Christine E Mona
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 11, 2020
Immune-Checkpoint Blockade Enhances <sup>225</sup>Ac-PSMA617 Efficacy in a Mouse Model of Prostate CancerJohannes Czernin, Kyle Current, Christine E Mona, et al.
EJNMMI Radiopharmacy and Chemistry|March 24, 2025
Hematological toxicity of [<sup>225</sup>Ac]Ac-PSMA-617 and [<sup>177</sup>Lu]Lu-PSMA-617 in RM1-PGLS syngeneic mouse modelMeryl Maria Vilangattil, Abir Swaidan, Jonathan Godinez, et al.
Organic & Biomolecular Chemistry|November 3, 2016
Design, synthesis, and biological evaluation of CXCR4 ligandsChristine E Mona, Élie Besserer-Offroy, Jérôme Cabana, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 16, 2025
FAP Expression in Renal Tumors Assessed by [<sup>68</sup>Ga]Ga-FAPI-46 PET Imaging and FAP Immunohistochemistry: A Case Series of Six Patients from the Prospective Exploratory Trial NCT04147494Adrien Holzgreve, Lena M Unterrainer, Kimberly Flores, et al.
Pharmacological Research|March 11, 2020
Cell-penetrating pepducins targeting the neurotensin receptor type 1 relieve painRebecca L Brouillette, Élie Besserer-Offroy, Christine E Mona, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 11, 2024
Preclinical evaluation of <sup>225</sup>Ac-labeled minigastrin analog DOTA-CCK-66 for Targeted Alpha TherapyNadine Holzleitner, Meryl Vilangattil, Abir Swaidan, et al.
Journal of Medicinal Chemistry|July 20, 2016
Structure-Activity Relationship and Signaling of New Chimeric CXCR4 AgonistsChristine E Mona, Élie Besserer-Offroy, Jérôme Cabana, et al.
ACS Pharmacology & Translational Science|July 15, 2026
Development of Radioligand Therapy-Responsive Syngeneic Prostate Models through Murine Prostate-Specific Membrane Antigen Point MutationMathis Richard, Beatrice Louis, Marco F Taddio, et al.
Clinical Nuclear Medicine|May 5, 2023
FAPI PET Signal in Hibernoma Reflects FAP Expression in Tumor Vasculature CellsMasatoshi Hotta, Christine E Mona, Joseph G Crompton, et al.
Pageof 3